Fractures are a common injury and can occur in any age group. While most fractures usually heal without any long-term consequences, some fractures can have a long-term impact on the patient’s quality of life. Old tough fractures, which are fractures that have been present for some time, can present a unique challenge for doctors. They may have been missed or misdiagnosed in the past, leading to a delay in treatment and potential long-term consequences. This article will provide a new look at old tough fractures and discuss the hidden potential for successful treatment.
Old tough fractures are fractures that have been present for more than six weeks. These fractures may have been missed or misdiagnosed in the past, leading to a delay in treatment. As a result, the fracture may have already begun to heal in an abnormal or incomplete manner. This can lead to long-term complications such as chronic pain, limited range of motion, and even deformity. When evaluating an old tough fracture, doctors must first assess the fracture and determine the degree of healing. This can be done through imaging studies such as X-rays and CT scans. Once the fracture has been assessed, doctors must then decide if the fracture can be treated or if it is too late and the fracture must be managed conservatively.
When treating an old tough fracture, doctors must first decide if the fracture can be treated surgically or if it must be managed conservatively. If the fracture is deemed treatable, then the doctor must decide which surgical technique is best for the patient. The most common surgical techniques for treating old tough fractures include open reduction and internal fixation (ORIF) and arthrodesis. Open reduction and internal fixation (ORIF) is a surgical procedure where the fracture is realigned and then held in place with metal implants. This technique is often used for fractures that are not healing properly and can be used to restore the normal shape of the bone. Arthrodesis is a surgical procedure where the fracture is realigned and then held in place with metal implants and bone grafts. This technique is often used for fractures that have already begun to heal in an abnormal or incomplete manner.
It is important to note that old tough fractures can have long-term complications even after successful treatment. These complications can include chronic pain, limited range of motion, and deformity. It is important for doctors to be aware of these potential complications and to discuss them with the patient prior to treatment.
Old tough fractures can present a unique challenge for doctors. These fractures may have been missed or misdiagnosed in the past, leading to a delay in treatment and potential long-term consequences. When evaluating an old tough fracture, doctors must assess the fracture and determine the degree of healing. If the fracture is deemed treatable, then the doctor must decide which surgical technique is best for the patient. It is important for doctors to be aware of the potential long-term complications of old tough fractures and to discuss them with the patient prior to treatment.
1.
Breast Cancer Patients Living Longer Post-Medicaid Expansion
2.
Error on the MGUS-Autoimmune Disease Association.
3.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
4.
The majority of cancer medications that receive expedited approval end up failing confirmatory trials.
5.
Unified Neuro/Psych Residency Program: New Proposal.
1.
Optimizing Melanoma Treatment: Strategies in Diagnosis, Clinical Research, and Physician Training
2.
Hemoglobin C: Understanding its Role in Sickle Cell Disease
3.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
4.
Understanding Abemaciclib: A Breakthrough Treatment for Breast Cancer
5.
The Growing Challenge of Haematological Malignancies in Older Adults
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
3.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
4.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation